Administrative and Clinical Services Core

行政和临床服务核心

基本信息

项目摘要

SUMMARY ABSTRACT The co-directors of the Administrative Core (AC) will be Drs. Nicholas Butowski (UCSF) and Roger Stupp (NU), who will share administrative and clinical responsibilities to provide oversight of the procedural and technical aspects of the planned projects and cores, ensuring compliance and scientific integrity of all components of the grant. They are also the co-PIs of this U19. Dr. Susan Chang will serve as co-investigator of the AC and provide extensive expertise in managing grants. The core leaders are accomplished brain tumor researchers, well qualified to supervise this U19 collaboration and ensure its productivity. Based on executive committee and internal advisory board recommendations, the core directors will make final decisions on any issues that involve the timely progression of the projects. Further, the core directors they will have overall scientific and financial responsibility for this U19. They will disburse funds and will receive regular accounting of the financial status of each project. The overall objective of the AC is to promote and facilitate the interactions of the members of this U19, provide necessary clinical research infrastructure and/or support for the projects, and coordinate activities of the U19 investigators. The specific aims of the AC are to provide administrative and clinical services to all our projects in order to accomplish their Specific Aims and Research Strategies. Administrative support will include fiscal grants management, clerical support for progress reports and manuscript preparation, organization of regular meetings among participants, and organization and administration of the Internal Advisory Board (IAB). The Administrative Core also facilitates communication with the Network Coordinating Center (NCC) and GTN Steering Committee.
总结抽象

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nicholas A Butowski其他文献

Nicholas A Butowski的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Nicholas A Butowski', 18)}}的其他基金

Administrative and Clinical Services Core
行政和临床服务核心
  • 批准号:
    10305130
  • 财政年份:
    2021
  • 资助金额:
    $ 21.89万
  • 项目类别:
Administrative and Clinical Services Core
行政和临床服务核心
  • 批准号:
    10487523
  • 财政年份:
    2021
  • 资助金额:
    $ 21.89万
  • 项目类别:
Advancing treatment and understanding of immunotherapy in glioblastoma
促进胶质母细胞瘤免疫疗法的治疗和理解
  • 批准号:
    10305129
  • 财政年份:
    2021
  • 资助金额:
    $ 21.89万
  • 项目类别:
Advancing treatment and understanding of immunotherapy in glioblastoma
促进胶质母细胞瘤免疫疗法的治疗和理解
  • 批准号:
    10689795
  • 财政年份:
    2021
  • 资助金额:
    $ 21.89万
  • 项目类别:
Advancing treatment and understanding of immunotherapy in glioblastoma
促进胶质母细胞瘤免疫疗法的治疗和理解
  • 批准号:
    10487522
  • 财政年份:
    2021
  • 资助金额:
    $ 21.89万
  • 项目类别:
A Phase I Study of CED of Liposomal-Irinotecan using imaging in High Grade Glioma
使用成像技术对高级别胶质瘤进行脂质体伊立替康 CED 的 I 期研究
  • 批准号:
    8827736
  • 财政年份:
    2014
  • 资助金额:
    $ 21.89万
  • 项目类别:
A Phase I Study of CED of Liposomal-Irinotecan using imaging in High Grade Glioma
使用成像技术对高级别胶质瘤进行脂质体伊立替康 CED 的 I 期研究
  • 批准号:
    8699561
  • 财政年份:
    2014
  • 资助金额:
    $ 21.89万
  • 项目类别:

相似海外基金

NSF Engines Development Award: Utilizing space research, development and manufacturing to improve the human condition (OH)
NSF 发动机发展奖:利用太空研究、开发和制造来改善人类状况(OH)
  • 批准号:
    2314750
  • 财政年份:
    2024
  • 资助金额:
    $ 21.89万
  • 项目类别:
    Cooperative Agreement
NSF Engines Development Award: Building an sustainable plastics innovation ecosystem in the Midwest (MN, IL)
NSF 引擎发展奖:在中西部(明尼苏达州、伊利诺伊州)建立可持续塑料创新生态系统
  • 批准号:
    2315247
  • 财政年份:
    2024
  • 资助金额:
    $ 21.89万
  • 项目类别:
    Cooperative Agreement
NSF Engines Development Award: Creating climate-resilient opportunities for plant systems (NC)
NSF 发动机开发奖:为工厂系统创造气候适应机会 (NC)
  • 批准号:
    2315399
  • 财政年份:
    2024
  • 资助金额:
    $ 21.89万
  • 项目类别:
    Cooperative Agreement
International Partnering Award: Using AI to assess senescence and mitochondrial morphology in calcifying VSMCs
国际合作奖:利用人工智能评估钙化 VSMC 的衰老和线粒体形态
  • 批准号:
    BB/Y513982/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.89万
  • 项目类别:
    Research Grant
Open Access Block Award 2024 - Durham University
2024 年开放访问区块奖 - 杜伦大学
  • 批准号:
    EP/Z531480/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.89万
  • 项目类别:
    Research Grant
Open Access Block Award 2024 - Goldsmiths College
2024 年开放获取区块奖 - 金史密斯学院
  • 批准号:
    EP/Z531509/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.89万
  • 项目类别:
    Research Grant
Open Access Block Award 2024 - John Innes Centre
2024 年开放访问区块奖 - 约翰·英尼斯中心
  • 批准号:
    EP/Z53156X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.89万
  • 项目类别:
    Research Grant
Open Access Block Award 2024 - London School of Economics & Pol Sci
2024 年开放获取区块奖 - 伦敦政治经济学院
  • 批准号:
    EP/Z531625/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.89万
  • 项目类别:
    Research Grant
Open Access Block Award 2024 - Oxford Brookes University
2024 年开放获取区块奖 - 牛津布鲁克斯大学
  • 批准号:
    EP/Z531728/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.89万
  • 项目类别:
    Research Grant
Open Access Block Award 2024 - The Francis Crick Institute
2024 年开放获取区块奖 - 弗朗西斯·克里克研究所
  • 批准号:
    EP/Z531844/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.89万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了